Tokyo, Japan

Naoto Kosuga



Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Tokyo, JP (2011 - 2013)
  • Shinjuku-ku, JP (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Naoto Kosuga: Innovator in Pharmaceutical Chemistry

Introduction

Naoto Kosuga is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various health conditions. With a total of 3 patents to his name, Kosuga's work is recognized for its innovative approach to drug development.

Latest Patents

Kosuga's latest patents include a 3-hydroxy-5-arylisothiazole derivative. This compound serves as a GPR40 activating agent, which is crucial for developing insulin secretagogues and therapeutic agents against diabetes and obesity. Another notable patent is the heterocyclidene acetamide derivative, which has applications in pharmaceutical compositions and as a TRPV1 receptor antagonist. These inventions highlight his commitment to addressing critical health issues through innovative chemical solutions.

Career Highlights

Kosuga is currently associated with Mochida Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Kosuga has collaborated with notable colleagues, including Daido Hotta and Hideharu Uchida. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Naoto Kosuga's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing health challenges. His patents reflect a dedication to improving medical treatments and enhancing the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…